The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $255,000 other transaction agreement (OTA) to McKinsey & Company, Inc. Washington D.C. to develop a design, process, and cost model for Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) Medical Countermeasure (MCM) production, including small molecules, biologics, and medical devices/supplies. The contract is not set-aside for any specific business type. McKinsey is a...
This is a $11,574,000 firm-fixed-price definitive contract awarded by the Department of the Air Force to McKinsey & Company, Inc. Washington D.C., a global management consulting firm, to provide COVID-19 task force support. The contract does not have a set-aside designation. McKinsey & Company, Inc. is the prime contractor and may utilize subcontractors, but specific subcontractor details are not provided. The contract was awarded on April 13, 2020 with a performance period ending on...
This federal contract was awarded by the Defense Health Agency (DHA) to McKinsey & Company, Inc. Washington D.C., a global management consulting firm, to provide COVID-19 testing strategies support activities. The contract is a definitive, firm-fixed-price contract with a ceiling value of $6,100,000.00 and a period of performance ending on April 27, 2021. The contract is not set aside for any socioeconomic category. McKinsey & Company, Inc. is the prime contractor and may utilize...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $742,652 firm fixed price purchase order to BCG Federal Corp. to provide COVID-19 support services. The contract supports the Army's response to the Coronavirus pandemic through services performed at Fort Detrick, Maryland from June 30, 2020 through October 31, 2020. BCG Federal Corp. will deliver COVID-19 related assistance as the prime contractor on this contract awarded under the National...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded a $6.5M firm fixed price delivery order contract to The Boston Consulting Group Inc., doing business as The Boston Consulting Group Inc., under its Multiple Award Schedule contract vehicle. The contract is for COVID-19 ACTION PROGRAM STRATEGY AND COMMUNICATION services to be performed at Fort Detrick, Maryland between September 30, 2022 and July 31, 2023. No applicable...
The Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a definitive contract valued at $8,305,020 to BCG Federal Corp. to provide consultant support services for the government's COVID-19 response efforts. Specifically, BCG Federal will assist with strategic communications, program analytics, clinical and non-clinical development, as well as chemistry, manufacturing, and controls. Performance will take place in Bethesda, Maryland over a one year base period...
The Department of the Air Force issued a $4.2 million delivery order against the Air Force Strategic Transformation Support (AFSTS) indefinite-delivery/indefinite-quantity contract to McKinsey & Company for COVID-19 task force support services. McKinsey will provide pandemic response assistance to the Defense Advanced Research Projects Agency through August 2022 under the firm-fixed-price order. As the prime contractor, McKinsey will leverage its expertise in management consulting, data...
The U.S. Department of Defense, Office of the Secretary of Defense, awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to McKinsey & Company, Inc. Washington D.C. to provide healthcare management consulting services for the Deputy Chief Management Officer (DCMO). The contract has a potential value of $2,694,209.48 and a completion date of March 29, 2019. This award is not associated with a set-aside designation. As a prime contractor and subcontractor, McKinsey has received...
The Department of Veterans Affairs (VA) awarded a $60,723,582.40 Firm Fixed Price contract to Mckinsey & Company, Inc. Washington D.C. for COVID-19 pandemic response and scenario planning services. The contract has a performance period extending to April 2024. This contract was awarded under a pre-solicitation notice seeking a contractor to provide epidemiological modeling and forecasting services to project COVID-19 infection and fatality rates across the U.S. and over 150 global...
McKinsey & Company, Inc. was awarded a $6.95 million firm fixed price purchase order by the Department of Health and Human Services' Food and Drug Administration to provide COVID-19 central coordination support services. The contract has a period of performance from April 10, 2020 through March 11, 2021 and will be performed in Silver Spring, Maryland. As the current pandemic requires a coordinated response, this award likely seeks consulting support to help streamline FDA processes and...